Trials / Completed
CompletedNCT00168454
A Research Study for Patients With Overactive Bladder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 313 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether injections of botulinum toxin Type A into the bladder are safe and effective in treating overactive bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | botulinum toxin Type A injected into detrusor on Day 1 |
| DRUG | Placebo | Placebo (normal saline) injected into detrusor on Day 1 |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2008-01-01
- Completion
- 2008-06-01
- First posted
- 2005-09-15
- Last updated
- 2013-11-06
- Results posted
- 2010-02-11
Locations
6 sites across 6 countries: United States, Belgium, Canada, Germany, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT00168454. Inclusion in this directory is not an endorsement.